Previous close | 19.70 |
Open | 19.70 |
Bid | 19.70 x 0 |
Ask | 20.00 x 0 |
Day's range | 19.70 - 19.70 |
52-week range | 17.70 - 27.80 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Healthpeak (PEAK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Healthpeak Properties (NYSE: PEAK) is a healthcare real estate investment trust that owns a portfolio of medical offices, life science properties, and senior housing communities. In this short video, Fool.
Healthpeak's (PEAK) Q4 results outshine estimates on better-than-anticipated revenues. Same-store net operating income for the total portfolio improves year over year. It issues 2023 guidance.
High demand for Healthpeak's (PEAK) life-science assets and rising healthcare spending by senior citizens are likely to have aided its Q4 earnings. Interest rate hikes might have been a deterrent.
Putting money in the bank is safe, but it also puts you at risk of missing out on an inevitable rally in the stock market.
Focus on enhancing life-science real-estate assets, increasing healthcare expenditure by senior citizens and capital-recycling moves drive Healthpeak's (PEAK) 10.4% QTD rise.
Healthpeak's (PEAK) focus on enhancing its life-science real-estate assets, capital-recycling moves and a solid balance sheet bodes well. Stiff competition from peers and rising interest rates are woes.
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. While...
Shares of Healthpeak Properties (NYSE: PEAK) jumped 10.3% in November, according to data provided by S&P Global Market Intelligence. Driving up shares of the real estate investment trust (REIT) was its third-quarter report. Healthpeak Properties posted solid third-quarter results last month.
Healthpeak Properties ( NYSE:PEAK ) Third Quarter 2022 Results Key Financial Results Revenue: US$520.4m (up 8.1% from...
Healthpeak (PEAK) reports decent Q3 results driven by healthy top-line growth. Same-store net operating income for the total portfolio improves year over year. It revises its 2022 guidance.
Healthpeak (PEAK) delivered FFO and revenue surprises of 0% and 0.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Rise in demand for Healthpeak's (PEAK) life-science assets, along with improving occupancy levels of the CCRC portfolio, is expected to have aided its Q3 earnings.
The mean of analysts' price targets for Healthpeak (PEAK) points to a 38% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Healthpeak Properties (NYSE:PEAK) has had a rough three months with its share price down 14%. To decide if this trend...
Air Products and Chemicals, Southern Copper Corporation, Discover Financial Services, Skyworks Solutions and Healthpeak Properties are part of the Zacks top Analyst Blog.
Today's Research Daily features new research reports on 16 major stocks, including Air Products and Chemicals, Inc. (APD), Southern Copper Corporation (SCCO) and Discover Financial Services (DFS).
A 10-year Treasury note now yields nearly 4% -- but that's still less than these three stocks offer.
Healthpeak (PEAK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Improving industry fundamentals and capital-recycling efforts will aid Healthpeak's (PEAK) growth. However, a spike in new variants of COVID-19 and higher interest rates are concerning.
Investing roughly $55,500 across these stocks will be enough to generate $300 in monthly dividend payments.
Healthpeak's (PEAK) Q2 results outpace estimates driven by solid top-line growth. Same-store net operating income for the total portfolio improves year over year. It reaffirms 2022 FFO guidance.
Healthpeak (PEAK) delivered FFO and revenue surprises of 2.33% and 2.41%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
You can invest in an index fund if you want to make sure your returns approximately match the overall market. By...